Patent · US Active

Composition and method for treating HPV

US9211338B2 · kind B2 · utility

0Cited by

0References

31Claims

0Family size

Assignees

UNIVERSITÉ LIBRE DE BRUXELLES · BE
Mithra Pharmaceuticals S.A. · BE

Inventors

Marie Piette · Wanze, BE
Brigitte Evrard · Embourg, BE
Isabelle Coïa · Koksijde, BE

Key dates

Filing date	Jul 13, 2012
Grant date	Dec 15, 2015
Priority date	—
Expiry date	Jul 13, 2032

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P35/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Described are lyophilized compositions comprising cidofovir, hydroxypropyl methylcellulose (HPMC) or hydroxyethylcellulose (HEC) and, optionally, a plasticizer. In particular, described are such compositions that form a sheet-shaped porous solid matrix. Also described are methods for producing such compositions and their use in treating human papillomavirus (HPV) infections and HPV-associated malignancies, in particular, HPV lesions and cervical cancer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.